Is “yo‑yo dieting” really harmful? New analysis challenges long‑standing assumptions about weight cycling

Is “Yo‑Yo Dieting” Really Harmful? New Analysis Challenges Long‑Standing Assumptions About Weight Cycling

Copenhagen, Denmark / Tübingen, Germany — Weight loss followed by weight regain, commonly known as “yo‑yo dieting” or weight cycling, is often portrayed as harmful, even more damaging than remaining overweight. But a new comprehensive analysis published in ‘The Lancet Diabetes & Endocrinology’ suggests this widely held belief is not supported by strong scientific evidence.

In an invited Personal View, Professors Faidon Magkos from the University of Copenhagen and Norbert Stefan from the German Center for Diabetes Research (DZD), the University Hospital Tübingen and Helmholtz Munich critically examine decades of research on weight cycling in humans and animals. Their conclusion: there is no convincing causal evidence that weight cycling itself leads to long‑term harm in patients with obesity.

“Many people struggling with weight are discouraged from trying to lose weight because they fear ‘yo‑yo dieting’ will lead to muscle loss and somehow damage their metabolism,” says Prof. Magkos. “Our review indicates that these fears are largely unsupported. In most cases, the benefits of trying to lose weight clearly outweigh the theoretical risks of weight cycling.”

A common experience with controversial reputation

For decades, weight cycling has been blamed for a range of adverse outcomes — increased fat gain, accelerated muscle loss, reduced metabolic rate, and higher risk of diabetes or cardiovascular disease. These concerns have shaped public messaging and even clinical advice, sometimes leading to the suggestion that repeated attempts at weight loss may “do more harm than good.”

The new analysis challenges this narrative.

What the evidence actually shows

The authors carefully evaluate observational studies, randomized clinical trials, and animal experiments that examine how repeated weight loss and regain affect body weight, body composition, energy metabolism, and glucose regulation.

“Once you properly account for pre‑existing health conditions, aging, and overall exposure to obesity, the supposed harmful effects of weight cycling largely disappear,” explains Prof. Stefan.

Importantly, studies that objectively track body composition show no consistent evidence that weight cycling causes disproportionate loss of lean (muscle) mass or long‑term suppression of metabolic rate. In most cases, people who regain weight return to a body composition similar to their starting point — not a worse one. Nor is there any robust evidence suggesting that weight cycling is behind the lifelong increase in weight often experienced by patients with obesity.

Weight regain is not the same as harm

The authors emphasize an important nuance: weight regain reverses many of the benefits of weight loss, such as improvements in blood sugar, blood pressure, and lipid levels. But this does not imply that a person is worse off than before they lost weight in the first place.

“Regaining weight brings people back toward baseline risk — not beyond it,” says Magkos. “There’s a crucial difference between losing benefits and causing harm.”

Indeed, several large studies show that when average body weight over time is taken into account, weight cycling no longer predicts diabetes or cardiovascular disease risk. Higher adiposity itself — not weight fluctuation — appears to be the dominant driver of metabolic risk.

Implications for modern obesity treatment

The findings are especially timely given the rapid rise of highly effective weight‑loss drugs, such as GLP‑1 and dual incretin agonists. These treatments can lead to large weight losses, followed by substantial regain if medication is discontinued — a pattern that mirrors weight cycling.

The authors argue that this should not be viewed as evidence of harm. Instead, intermittent weight reduction — even if not permanently maintained — can provide meaningful periods of improved metabolic health and quality of life.

Reassuring message for patients and clinicians

Magkos and Stefan conclude with a clear take‑home message: people living with overweight or obesity should not be discouraged from pursuing weight loss, even if long‑term maintenance proves difficult.

“The idea that ‘yo‑yo dieting ruins your metabolism’ is not supported by robust evidence,” they say. “Trying — and even failing — to lose weight is not harmful. But giving up altogether may be.”

Publication:

Magkos F, Stefan N. Is weight cycling clinically harmful? The Lancet Diabetes & Endocrinology, Published Online, https://doi.org/10.1016/S2213-8587(26)00037-9

Scientific contacts:

Prof. Faidon Magkos

Department of Nutrition, Exercise and Sports (NEXS)

University of Copenhagen, Frederiksberg C, Denmark

Phone: +45 3533 3671

Email: fma@nexs.ku.dk

Prof. Norbert Stefan

Helmholtz Centre Munich

University Hospital Tübingen

Phone: +49 7071 2980390

Email: norbert.stefan@med.uni-tuebingen.de

The German Center for Diabetes Research (DZD e.V.) is one of the eight German Centers for Health Research. It brings together experts in the field of diabetes research and combines basic research, epidemiology and clinical application. The aim of the DZD is to make a significant contribution to the successful, customized prevention, diagnosis and treatment of diabetes mellitus through a novel, integrative research approach. www.dzd-ev.de/en

Helmholtz Munich is a biomedical research center of excellence. Its mission is to develop groundbreaking solutions for a healthier society in a rapidly changing world. Interdisciplinary research teams focus on environmental diseases, in particular the treatment and prevention of diabetes, obesity, allergies and chronic lung diseases. www.helmholtz-munich.de/en. The Institute of Diabetes Research and Metabolic Diseases of Helmholtz Munich is affiliated with the University of Tübingen.